Lin F - Search Results

1

IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production.

Liu J, Lin F, Strainic MG, An F, Miller RH, Altuntas CZ, Heeger PS, Tuohy VK, Medof ME. Liu J, et al. Among authors: lin f. J Immunol. 2008 May 1;180(9):5882-9. doi: 10.4049/jimmunol.180.9.5882. J Immunol. 2008. PMID: 18424707 Free PMC article.

2

Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis.

Lin F, Salant DJ, Meyerson H, Emancipator S, Morgan BP, Medof ME. Lin F, et al. J Immunol. 2004 Feb 15;172(4):2636-42. doi: 10.4049/jimmunol.172.4.2636. J Immunol. 2004. PMID: 14764738

3

Decay-accelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: role for complement in inflammatory bowel disease.

Lin F, Spencer D, Hatala DA, Levine AD, Medof ME. Lin F, et al. J Immunol. 2004 Mar 15;172(6):3836-41. doi: 10.4049/jimmunol.172.6.3836. J Immunol. 2004. PMID: 15004190

4

Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production.

Lalli PN, Strainic MG, Lin F, Medof ME, Heeger PS. Lalli PN, et al. Among authors: lin f. J Immunol. 2007 Nov 1;179(9):5793-802. doi: 10.4049/jimmunol.179.9.5793. J Immunol. 2007. PMID: 17947652 Free PMC article.

5

Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis.

Lalli PN, Strainic MG, Yang M, Lin F, Medof ME, Heeger PS. Lalli PN, et al. Among authors: lin f. Blood. 2008 Sep 1;112(5):1759-66. doi: 10.1182/blood-2008-04-151068. Epub 2008 Jun 20. Blood. 2008. PMID: 18567839 Free PMC article.

6

Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.

Strainic MG, Shevach EM, An F, Lin F, Medof ME. Strainic MG, et al. Among authors: lin f. Nat Immunol. 2013 Feb;14(2):162-71. doi: 10.1038/ni.2499. Epub 2012 Dec 23. Nat Immunol. 2013. PMID: 23263555 Free PMC article.

7

Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis.

Lin F, Emancipator SN, Salant DJ, Medof ME. Lin F, et al. Lab Invest. 2002 May;82(5):563-9. doi: 10.1038/labinvest.3780451. Lab Invest. 2002. PMID: 12003997 Free article.

8

Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection.

Lin F, Kaminski HJ, Conti-Fine BM, Wang W, Richmonds C, Medof ME. Lin F, et al. J Clin Invest. 2002 Nov;110(9):1269-74. doi: 10.1172/JCI16086. J Clin Invest. 2002. PMID: 12417565 Free PMC article.

9

Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis.

Kaminski HJ, Li Z, Richmonds C, Lin F, Medof ME. Kaminski HJ, et al. Among authors: lin f. Exp Neurol. 2004 Oct;189(2):333-42. doi: 10.1016/j.expneurol.2004.06.005. Exp Neurol. 2004. PMID: 15380483

10

Decay-accelerating factor modulates induction of T cell immunity.

Heeger PS, Lalli PN, Lin F, Valujskikh A, Liu J, Muqim N, Xu Y, Medof ME. Heeger PS, et al. Among authors: lin f. J Exp Med. 2005 May 16;201(10):1523-30. doi: 10.1084/jem.20041967. Epub 2005 May 9. J Exp Med. 2005. PMID: 15883171 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,020 results

Search Page

Filters